海王生物(000078.SZ):已按期償還“17海王01”、“18海王01”
格隆匯 7 月 3日丨海王生物(000078.SZ)公佈,公司於2017年6月26日成功發行2017年面向合格投資者公開發行公司債券(第一期),債券簡稱“17海王01”,債券代碼為112535,債券到期日為2020年6月26日,債券的最終發行規模為人民幣8億元,票面利率為6.48%。公司於2018年7月4日成功發行2018年非公開發行公司債券(第一期),債券簡稱“18海王01”,債券代碼為114353,債券到期日為2021年7月4日。債券發行實際募集資金8億元,最終票面利率為7.0%。
截止公告日,公司已經完成“17海王01”公開發行公司債、“18海王01”非公開發行公司債的全部資金償還,其中償還“17海王01”公司債剩餘金額本息費用合計人民幣107,007,490.11元,“18海王01”公司債本息費用合計人民幣856,042,800.00元,公司累計償還總金額為人民幣963,050,290.11元。
後續公司將繼續拓展多樣化的融資渠道,優化公司財務結構,提高資金使用效率,為公司持續健康發展提供保障。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.